Pyroptosis-Derived Long Noncoding RNA Profiles Reveal a Novel Signature for Evaluating the Prognosis of Patients With Lung Adenocarcinoma.
Yuhao BaShutong LiuZhengpan WeiNannan ZhaoTong QiaoYuqing RenLifeng LiYuyuan ZhangSiyuan WengHui XuChunwei LiXiaoyong GeXin-Wei HanPublished in: JCO precision oncology (2024)
We provided novel insight and established a pyroptosis-derived lncRNA signature for patients with LUAD, exhibiting strong predictive capabilities in both the training and validation sets.